Chlorotonil A
Chlorotonil A is an orally active Antibacterial and antimalarial agent. Chlorotonil A is isolated from Sorangium cellulosum. Chlorotonil A inhibits the germination of Clostridioides difficile spores into vegetative cells. Chlorotonil A exhibits antibacterial activity against Gram-positive bacteria and gametocytocidal activity against mature Plasmodium falciparum gametocytes. Chlorotonil A reduces parasitemia in the murine Plasmodium berghei model and prevents recurrent C. difficile infection in mice. Chlorotonil A can be used for research on malaria and Clostridioides difficile infection.
For research use only. We do not sell to patients.
- CAS No.: 1009813-26-6
- Formula: C26H32Cl2O4
- Molecular Weight:479.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[3]|
Microbial Metabolite |
In Vitro
Chlorotonil A exhibits high activity against late-stage Plasmodium falciparum gametocytes in vitro, with an IC50 of 0.030 μM[1].
Chlorotonil A (6.4 μg/mL-12.5 ng/mL; 24 h) exhibits potent bactericidal antibacterial activity against multiple Clostridioides difficile strains, including strains resistant to Vancomycin (HY-B0671), Metronidazole (HY-B0318), and Fidaxomicin (HY-17580), with MIC/MBC values of 0.4 to 1.6 μg/mL[3].
Chlorotonil A (0.1 μg/mL and above) inhibits the outgrowth of C. difficile VPI10463 spores into vegetative cells, with complete inhibition observed at concentrations of 0.4 μg/mL and above[3].
Chlorotonil A exhibits potent antibacterial activity against Staphylococcus aureus and Streptococcus pneumoniae, and potent antiplasmodial activity against Plasmodium falciparum[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
Chlorotonil A (40 mg/kg; p.o.) maintains colonization resistance against C. difficile in mice, preventing colonization and disease[3].
Chlorotonil A (2 × 5 mg/kg; intravenous injection) reduces the bacterial burden of Staphylococcus aureus by approximately 4 log units in a mouse thigh infection model[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6N SPF mice (female and male, 6-30 weeks old)[3]
-
Dosage:40 mg/kg
-
Administration:p.o.; on days 1 and 2; or on day −1 as pre-treatment
-
Result:Achieved a final survival rate of 66.6% (6/9 mice).
Cleared C. difficile completely by day 7 in 83.3% of surviving mice (5/6).
Reduced amounts of toxins approximately 100-fold compared with vancomycin-treated mice at day 5.
Resulted in significantly slower onset of disease and minor severity compared with control in the pre-treatment experiment.
-
Animal Model:C57BL/6N SPF mice (female and male, 6-30 weeks old)[3]
-
Dosage:40 mg/kg
-
Administration:p.o.; single dose
-
Result:Did not lead to phenotypic disease.
No vegetative cells or spores were detected in ChA-treated mice.
-
Animal Model:Mice[4]
-
Dosage:2 × 5 mg/kg
-
Administration:i.v.
-
Result:Reduced bacterial burden in the thigh by approximately 4 log.
Chemical Information
-
CAS No. 1009813-26-6
-
Molecular Weight 479.44
-
Formula C26H32Cl2O4
-
SMILES
O=C1C(Cl)(Cl)C([C@H](C)C(O[C@@H](C)/C=C/C=C\[C@@H](C)[C@@]2([H])[C@]1([H])[C@]3([H])[C@H](C)C=C(C)C[C@@]3([H])C=C2)=O)=O
-
Structure Classification
-
Initial Source
Sorangium cellulosum
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Chlorotonil A
- 1009813-26-6
- Antibiotic
- Endogenous Metabolite
- Bacterial
- Parasite
- Sorangium cellulosum Soce1525
- HepG2 cells
- Plasmodium falciparum
- spore outgrowth
- Staphylococcus aureus
- colonization resistance
- B. subtilis 168 pCHlux101-PiseA
- Plasmodium berghei
- Streptococcus pneumoniae
- Clostridioides difficile
- Inhibitor
- inhibitor
- inhibit